JP2005508150A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508150A5 JP2005508150A5 JP2003515650A JP2003515650A JP2005508150A5 JP 2005508150 A5 JP2005508150 A5 JP 2005508150A5 JP 2003515650 A JP2003515650 A JP 2003515650A JP 2003515650 A JP2003515650 A JP 2003515650A JP 2005508150 A5 JP2005508150 A5 JP 2005508150A5
- Authority
- JP
- Japan
- Prior art keywords
- variant
- lactobacillus casei
- casei strain
- lactobacillus
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000199866 Lactobacillus casei Species 0.000 description 24
- 235000013958 Lactobacillus casei Nutrition 0.000 description 24
- 229940017800 lactobacillus casei Drugs 0.000 description 24
- 230000002265 prevention Effects 0.000 description 10
- 238000009472 formulation Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 230000002757 inflammatory effect Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 241000186660 Lactobacillus Species 0.000 description 7
- 229940039696 lactobacillus Drugs 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000001815 biotherapy Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000002551 irritable bowel syndrome Diseases 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 230000000529 probiotic effect Effects 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 241000193163 Clostridioides difficile Species 0.000 description 2
- 206010009900 Colitis ulcerative Diseases 0.000 description 2
- 208000011231 Crohn disease Diseases 0.000 description 2
- 241000257303 Hymenoptera Species 0.000 description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 2
- 201000006704 Ulcerative Colitis Diseases 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 206010009887 colitis Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000008476 powdered milk Nutrition 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000000770 proinflammatory effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- BVPWJMCABCPUQY-UHFFFAOYSA-N 4-amino-5-chloro-2-methoxy-N-[1-(phenylmethyl)-4-piperidinyl]benzamide Chemical compound COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CC=2C=CC=CC=2)CC1 BVPWJMCABCPUQY-UHFFFAOYSA-N 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 208000002389 Pouchitis Diseases 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 235000020167 acidified milk Nutrition 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000031261 interleukin-10 production Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE20010715 | 2001-07-26 | ||
| IE20010699 | 2001-07-26 | ||
| IE20010700 | 2001-07-26 | ||
| IE20010706 | 2001-07-26 | ||
| IE20010712 | 2001-07-26 | ||
| PCT/IE2002/000112 WO2003010299A1 (en) | 2001-07-26 | 2002-07-26 | Probiotic lactobacillus casei strains |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508150A JP2005508150A (ja) | 2005-03-31 |
| JP2005508150A5 true JP2005508150A5 (enExample) | 2006-01-05 |
Family
ID=27517571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003515650A Pending JP2005508150A (ja) | 2001-07-26 | 2002-07-26 | プロバイオティックラクトバチラスカゼイ株類 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20030113306A1 (enExample) |
| EP (1) | EP1409643A1 (enExample) |
| JP (1) | JP2005508150A (enExample) |
| CN (1) | CN1556853A (enExample) |
| BR (1) | BR0211438A (enExample) |
| CA (1) | CA2454805A1 (enExample) |
| IL (1) | IL160050A0 (enExample) |
| PE (1) | PE20030283A1 (enExample) |
| WO (1) | WO2003010299A1 (enExample) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| US7182943B2 (en) * | 2002-05-15 | 2007-02-27 | UNIVERSITé LAVAL | Method and system for modulation of microbial cell characteristics |
| EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
| US20040197304A1 (en) | 2003-04-01 | 2004-10-07 | The Procter & Gamble Company And Alimentary Health, Ltd. | Methods of determining efficacy of treatments of inflammatory diseases of the bowel |
| US20040265279A1 (en) * | 2003-05-08 | 2004-12-30 | Timothy Dinan | Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity |
| US20050271643A1 (en) * | 2003-08-14 | 2005-12-08 | Iryna Sorokulova | Bacterial strains, compositions including same and probiotic use thereof |
| WO2005030230A1 (en) * | 2003-09-30 | 2005-04-07 | Probiomics Limited | Compositions and methods for treatment or prevention of psoriasis and related disorders |
| US8871266B2 (en) * | 2003-10-01 | 2014-10-28 | Commonwealth Scientific & Industrial Research Organisation | Probiotic storage and delivery |
| AU2004275438B2 (en) * | 2003-10-01 | 2008-05-29 | Commonwealth Scientific & Industrial Research Organisation | Probiotic storage and delivery |
| US8894991B2 (en) * | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
| US7785635B1 (en) * | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US20050152884A1 (en) | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
| JP4938005B2 (ja) | 2005-05-31 | 2012-05-23 | ザ・アイムス・カンパニー | ネコ科動物プロバイオティックであるラクトバシラス |
| BRPI0611492B1 (pt) | 2005-05-31 | 2021-10-13 | Mars, Incorporated | Bifidobactéria probiótica felina |
| ES2333259T3 (es) * | 2005-11-21 | 2010-02-18 | Bioatlantis Limited | Composiciones destinadas a mejorar la salud intestinal y el rendimiento en animales que comprenden beta-glucanos y alfa-fucanos. |
| CA2673465A1 (en) | 2007-02-01 | 2008-08-07 | The Iams Company | Method for decreasing inflammation and stress in a mammal |
| CN105796607A (zh) * | 2007-02-28 | 2016-07-27 | Mjn 美国控股有限责任公司 | 用于儿童或婴幼儿的含有灭活益生菌的产品 |
| CN101144065B (zh) * | 2007-09-03 | 2011-11-09 | 江南大学 | 一种耐过氧化氢、清除自由基的抗氧化干酪乳杆菌及其用途 |
| EP2065048A1 (en) * | 2007-11-30 | 2009-06-03 | Institut Pasteur | Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| WO2010013143A2 (en) * | 2008-08-01 | 2010-02-04 | Institut Pasteur | Methods for inhibiting mast cell activation and treating mast cell-dependent inflammatory diseases and disorders using lactobacillus |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| JP5852558B2 (ja) * | 2010-03-26 | 2016-02-03 | 株式会社明治 | 腸管免疫の抑制剤のスクリーニング方法 |
| WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物 |
| US9011909B2 (en) | 2010-09-03 | 2015-04-21 | Wisconsin Pharmacal Company, Llc | Prebiotic suppositories |
| EP3569690B1 (en) | 2011-12-01 | 2024-08-28 | The University of Tokyo | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
| WO2014128737A1 (en) * | 2013-02-25 | 2014-08-28 | Italchimici S.P.A. | Dietary food for the treatment of inflammatory bowel diseases |
| CN104031855A (zh) * | 2013-03-08 | 2014-09-10 | 任发政 | 干酪乳杆菌及其应用以及功能食品组合物及其制备方法 |
| CN104651245B (zh) * | 2013-11-15 | 2017-10-13 | 景岳生物科技股份有限公司 | 用于治疗微小核糖核酸病毒感染的益生菌组合物及其用途 |
| US20150139968A1 (en) * | 2013-11-15 | 2015-05-21 | Genmont Biotech Inc. | Probiotic composition for treating picornavirus infection and its use thereof |
| US20150209468A1 (en) | 2014-01-24 | 2015-07-30 | The Procter & Gamble Company | Hygiene article containing microorganism |
| US20150209469A1 (en) | 2014-01-24 | 2015-07-30 | The Procter & Gamble Company | Web Comprising a Microorganism-Containing Fibrous Element and Methods for Making Same |
| US20150209392A1 (en) | 2014-01-24 | 2015-07-30 | The Procter & Gamble Company | Filaments Comprising a Microorganism and Method for Making Same |
| WO2016008084A1 (zh) * | 2014-07-15 | 2016-01-21 | 王国全 | 自体来源乳酸菌的制造方法及系统 |
| US20160354507A1 (en) | 2015-06-07 | 2016-12-08 | The Procter & Gamble Company | Article of commerce containing absorbent article |
| CN108135945A (zh) * | 2015-06-22 | 2018-06-08 | 哈佛大学校长及研究员协会 | 固有层调节性t细胞的诱导 |
| US20170020750A1 (en) | 2015-07-23 | 2017-01-26 | The Procter & Gamble Company | Patch containing microorganism |
| CN105087439B (zh) * | 2015-08-19 | 2017-12-12 | 内蒙古农业大学 | 一种高抗阿莫西林干酪乳杆菌及其选育方法 |
| EP3341082B1 (en) | 2015-08-27 | 2020-12-16 | PrecisionBiotics Group Limited | Bifidobacterium longum |
| TWI598103B (zh) * | 2016-08-22 | 2017-09-11 | 景岳生物科技股份有限公司 | 改善困難梭狀桿菌感染症狀的發酵乳酸桿菌ｇｍｎｌ－２９６組合物及方法 |
| US11813297B2 (en) | 2017-03-23 | 2023-11-14 | Katholieke Universiteit Leuven, Ku Leuven R & D | Probiotic Lactobacillus casei strain and its uses |
| AU2017100632A4 (en) * | 2017-05-29 | 2017-07-06 | Bgi Shenzhen | An oral liquid probiotic formulation and method of preventing and/or treating arthritis |
| IT201700101704A1 (it) * | 2017-09-12 | 2019-03-12 | Sofar Spa | Nuovo uso per trattamento delle infezioni da clostridium difficile |
| CN109486700A (zh) * | 2018-08-31 | 2019-03-19 | 石家庄君乐宝乳业有限公司 | 副干酪乳杆菌n1115预防结肠炎的应用及相应的益生菌粉、应用 |
| CN110591950B (zh) * | 2019-09-23 | 2021-05-28 | 江南大学 | 一株可以提高肠道il-22表达量的干酪乳杆菌 |
| CN110893195B (zh) * | 2019-09-30 | 2023-03-14 | 内蒙古伊利实业集团股份有限公司 | 一种具有缓解肠道炎症功能的副干酪乳杆菌et-22 |
| CN110669697B (zh) | 2019-10-31 | 2022-07-15 | 微康益生菌(苏州)股份有限公司 | 一种高产短链脂肪酸的干酪乳杆菌、培养方法及其应用 |
| CN118020940A (zh) * | 2019-11-29 | 2024-05-14 | 内蒙古伊利实业集团股份有限公司 | 副干酪乳杆菌k56提升肠道细菌感染抗性和肠道免疫力的应用 |
| CN112869170B (zh) * | 2019-11-29 | 2023-05-23 | 伊利伊诺科技(上海)有限责任公司 | 可提高胃肠道免疫能力的益生菌益生元营养组合物及应用 |
| CN112375722B (zh) * | 2021-01-18 | 2021-04-13 | 山东中科嘉亿生物工程有限公司 | 一种改善过敏的干酪乳杆菌lc-12及其产品、应用 |
| CN113088468B (zh) * | 2021-04-09 | 2022-06-03 | 中国农业大学 | 干酪乳杆菌Ma.GLRGJ 1及其应用 |
| CN117089505B (zh) * | 2023-10-20 | 2024-03-19 | 杭州微致生物科技有限公司 | 一种副干酪乳杆菌vb306及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55113718A (en) * | 1979-02-27 | 1980-09-02 | Yakult Honsha Co Ltd | Antitumor agent |
| GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
| MXPA99007378A (es) * | 1997-02-11 | 2005-04-19 | Entpr Ireland | Cepas probioticas de lactobacillus salivarius y agentes antimicrobianos obtenidos a partir de lasmismas. |
| EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
| AUPQ415899A0 (en) * | 1999-11-19 | 1999-12-16 | Vasse Research Institute Pty Ltd | Compositions for and methods of treatment of allergic diseases |
| ATE391509T1 (de) * | 2000-12-18 | 2008-04-15 | Probio Health | Von lactobacillus casei ke01 stamm abgeleitete probiotische verbindungen |
-
2002
- 2002-07-24 PE PE2002000656A patent/PE20030283A1/es not_active Application Discontinuation
- 2002-07-25 US US10/201,917 patent/US20030113306A1/en not_active Abandoned
- 2002-07-26 IL IL16005002A patent/IL160050A0/xx unknown
- 2002-07-26 WO PCT/IE2002/000112 patent/WO2003010299A1/en not_active Ceased
- 2002-07-26 JP JP2003515650A patent/JP2005508150A/ja active Pending
- 2002-07-26 EP EP02762735A patent/EP1409643A1/en not_active Withdrawn
- 2002-07-26 CN CNA02818579XA patent/CN1556853A/zh active Pending
- 2002-07-26 CA CA002454805A patent/CA2454805A1/en not_active Abandoned
- 2002-07-26 BR BR0211438-0A patent/BR0211438A/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508150A5 (enExample) | ||
| JP2005506063A5 (enExample) | ||
| JP2005508617A5 (enExample) | ||
| Mombelli et al. | The use of probiotics in medical practice | |
| ES2460891T3 (es) | Uso de lactobacilus para el tratamiento de enfermedades autoinmunes | |
| TWI574633B (zh) | 包含益生菌及益生質成分及礦物鹽及乳鐵蛋白之組合物 | |
| Ren et al. | Evaluation of immunomodulatory activity of two potential probiotic Lactobacillus strains by in vivo tests | |
| CA2454804A1 (en) | Probiotic lactobacillus salivarius strains | |
| JP6889699B2 (ja) | 特定栄養用途のための安定乾燥プロバイオティクス組成物 | |
| RU2009136395A (ru) | ПРОБИОТИЧЕСКИЕ ШТАММЫ Bifidobacterium | |
| JP2010522552A5 (enExample) | ||
| RU2009136394A (ru) | ПРОБИОТИЧЕСКИЕ ШТАММЫ Bifidobacterium | |
| WO1999064023A1 (en) | Lactic acid bacterium-containing compositions, drugs and foods | |
| ES2716973T3 (es) | Lactobacillus rhamnosus RHT-3201 conjugado con aglutinante polimérico polisacárido y uso del mismo para la prevención o tratamiento de enfermedades atópicas | |
| RU2012117973A (ru) | Пробиотический штамм бифидобактерий | |
| US11446338B2 (en) | Food, cosmetic and pharmaceutical formulation with an immunomodulatory and protective anti-viral effect | |
| JP3017493B1 (ja) | 自己免疫疾患予防組成物 | |
| JP2005513111A (ja) | 消化管の特定部分に物質を統制送達（ａｄｉｒｅｃｔｅｄｄｅｌｉｖｅｒｙ）するための微生物の使用 | |
| JP2007308419A (ja) | 腸管免疫活性化剤及びＩｇＡ抗体産生促進剤、並びにこれらが含まれた食品、動物飼料及び医薬品 | |
| JP6302239B2 (ja) | 抗腫瘍剤及びその製造方法 | |
| CA2493644C (en) | Composition for promoting the proliferation of lactobacillus casei subsp. casei | |
| CN103154235A (zh) | 乳杆菌属菌株的免疫调节性质的改善 | |
| JP5209294B2 (ja) | インターロイキン１２産生促進剤 | |
| EP3389399B1 (en) | Microparticles for encapsulating probiotics, obtaining said microparticles and uses thereof | |
| RU2004101954A (ru) | Пробиотические штаммы lactobacillus salivarius |